{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:47:22Z","timestamp":1774957642724,"version":"3.50.1"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2020.00067","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T04:19:57Z","timestamp":1588047597000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["DNA Damage, an Innocent Bystander in Atrial Fibrillation and Other Cardiovascular Diseases?"],"prefix":"10.3389","volume":"7","author":[{"given":"Kennedy S.","family":"Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca J. J. M.","family":"Brundel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/CLEP.S47385","article-title":"Epidemiology of atrial fibrillation: European perspective","volume":"6","author":"Zoni-Berisso","year":"2014","journal-title":"Clin Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12471-011-0175-4","article-title":"The burden of atrial fibrillation in the Netherlands","volume":"19","author":"Heemstra","year":"2011","journal-title":"Neth Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cjca.2017.11.022","article-title":"Sex differences in atrial fibrillation","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.cjca.2014.03.022","article-title":"Epidemiology of acquired valvular heart disease","volume":"30","author":"Iung","year":"2014","journal-title":"Can J Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1389202916666150108222031","article-title":"Your father and grandfather's atrial fibrillation: a review of the genetics of the most common pathologic cardiac dysrhythmia","volume":"16","author":"Palatinus","year":"2015","journal-title":"Curr Genomics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/cvr\/cvv283","article-title":"Common variation in atrial fibrillation: navigating the path from genetic association to mechanism","volume":"109","author":"Tucker","year":"2016","journal-title":"Cardiovasc Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1631","DOI":"10.1161\/CIRCGENETICS.116.001631","article-title":"Lamin A\/C-related cardiac disease: late onset with a variable and mild phenotype in a large cohort of patients with the lamin A\/C p","volume":"10","author":"Hoorntje","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1399-0004.2010.01512.x","article-title":"Desmin-related myopathy","volume":"80","author":"van Spaendonck-Zwarts","year":"2011","journal-title":"Clin Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jaccao.2019.09.008","article-title":"Increased cancer prevalence in peripartum cardiomyopathy","volume":"1","author":"Pfeffer","year":"2019","journal-title":"JACC Cardio Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1093\/europace\/eux274","article-title":"HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.5603\/KP.2016.0172","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/s41467-019-09014-2","article-title":"DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA damage, repair, and mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ Mol Mutagen"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1007\/s00018-016-2130-4","article-title":"The DNA damage-induced cell death response: a roadmap to kill cancer cells","volume":"73","author":"Matt","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"14258","DOI":"10.1021\/ja906135d","article-title":"Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications","volume":"131","author":"Tao","year":"2009","journal-title":"J Am Chem Soc"},{"key":"B16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0076-6879(05)09029-4","article-title":"Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair","volume":"409","author":"Dantzer","year":"2006","journal-title":"Methods Enzymol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-12-407696-9.00005-1","article-title":"Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis","volume":"304","author":"Feng","year":"2013","journal-title":"Int Rev Cell Mol Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.mam.2012.12.010","article-title":"Poly(ADP-ribose): PARadigms and PARadoxes","volume":"34","author":"Burkle","year":"2013","journal-title":"Mol Aspects Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.2741\/2909","article-title":"The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases","volume":"13","author":"Hassa","year":"2008","journal-title":"Front Biosci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1432-1033.1979.tb04225.x","article-title":"The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma-radiation and N-methyl-N-nitrosourea","volume":"101","author":"Skidmore","year":"1979","journal-title":"Eur J Biochem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"113218","DOI":"10.1016\/j.expneurol.2020.113218","article-title":"Acute sources of mitochondrial NAD+ during respiratory chain dysfunction","volume":"327","author":"Chinopoulos","year":"2020","journal-title":"Exp Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0006-291X(03)01483-9","article-title":"NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes","volume":"308","author":"Ying","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1126\/science.8080500","article-title":"Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity","volume":"263","author":"Zhang","year":"1994","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1101\/gad.1199904","article-title":"Alkylating DNA damage stimulates a regulated form of necrotic cell death","volume":"18","author":"Zong","year":"2004","journal-title":"Genes Dev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1523\/JNEUROSCI.5552-09.2010","article-title":"NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death","volume":"30","author":"Alano","year":"2010","journal-title":"J Neurosci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.freeradbiomed.2009.05.004","article-title":"Mitochondria and reactive oxygen species","volume":"47","author":"Kowaltowski","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/nar\/gkp100","article-title":"Oxidative stress induces degradation of mitochondrial DNA","volume":"37","author":"Shokolenko","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"19881","DOI":"10.1074\/jbc.M114.571588","article-title":"Nucleosomes suppress the formation of double-strand DNA breaks during attempted base excision repair of clustered oxidative damages","volume":"289","author":"Cannan","year":"2014","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/CIRCULATIONAHA.113.005300","article-title":"Activation of histone deacetylase-6 induces contractile dysfunction through derailment of alpha-tubulin proteostasis in experimental and human atrial fibrillation","volume":"129","author":"Zhang","year":"2014","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0008-6363(01)00354-6","article-title":"Heat shock proteins and cardiac protection","volume":"51","author":"Latchman","year":"2001","journal-title":"Cardiovasc Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/01.CIR.103.5.684","article-title":"Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation","volume":"103","author":"Brundel","year":"2001","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0735-1097(00)01195-5","article-title":"Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels","volume":"37","author":"Brundel","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1007\/s00018-006-6345-7","article-title":"Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblasts","volume":"63","author":"Fiorillo","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1073\/pnas.94.2.679","article-title":"Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle","volume":"94","author":"Thiemermann","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0008-6363(97)00137-5","article-title":"Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase","volume":"36","author":"Zingarelli","year":"1997","journal-title":"Cardiovasc Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1124\/jpet.104.077164","article-title":"Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure","volume":"312","author":"Xiao","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0735-1097(02)02062-4","article-title":"Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure","volume":"40","author":"Pacher","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3760\/cma.j.issn.0366-6999.20121234","article-title":"Poly (ADP-ribose) polymerase inhibitor reduces heart ischaemia\/reperfusion injury via inflammation and Akt signalling in rats","volume":"126","author":"Song","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra0902923","article-title":"Inherited cardiomyopathies","volume":"364","author":"Watkins","year":"2011","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0169189","DOI":"10.1371\/journal.pone.0169189","article-title":"A novel lamin a mutant responsible for congenital muscular dystrophy causes distinct abnormalities of the cell nucleus","volume":"12","author":"Barateau","year":"2017","journal-title":"PLoS ONE"},{"key":"B43","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrcardio.2017.89","article-title":"Proteostasis in cardiac health and disease","volume":"14","author":"Henning","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature12105","article-title":"Lamin A\/C and emerin regulate MKL1-SRF activity by modulating actin dynamics","volume":"497","author":"Ho","year":"2013","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/hmg\/ddy227","article-title":"Microtubule cytoskeleton regulates connexin 43 localization and cardiac conduction in cardiomyopathy caused by mutation in A-type lamins gene","volume":"28","author":"Macquart","year":"2019","journal-title":"Hum Mol Genet"},{"key":"B46","doi-asserted-by":"crossref","first-page":"16321","DOI":"10.1016\/S0021-9258(19)85424-8","article-title":"Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C","volume":"268","author":"Lin","year":"1993","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yjmcc.2018.10.017","article-title":"Amelioration of desmin network defects by \u03b1B-crystallin overexpression confers cardioprotection in a mouse model of dilated cardiomyopathy caused by LMNA gene mutation","volume":"125","author":"Galata","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1161\/CIRCRESAHA.118.314238","article-title":"DNA damage response\/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with LMNA (Lamin A\/C) mutations","volume":"124","author":"Chen","year":"2019","journal-title":"Circ Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1161\/CIRCULATIONAHA.116.026099","article-title":"Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy","volume":"137","author":"Diguet","year":"2018","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1093\/hmg\/ddy278","article-title":"Rescue of biosynthesis of nicotinamide adenine dinucleotide protects the heart in cardiomyopathy caused by lamin A\/C gene mutation","volume":"27","author":"Vignier","year":"2018","journal-title":"Hum Mol Genet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1091\/mbc.E18-10-0650","article-title":"NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival","volume":"30","author":"Murata","year":"2019","journal-title":"Mol Biol Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","article-title":"Pathophysiology and epidemiology of peripartum cardiomyopathy","volume":"11","author":"Hilfiker-Kleiner","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/01.NAJ.0000605352.84144.a2","article-title":"CE: gestational hypertension, preeclampsia, and peripartum cardiomyopathy: a clinical review","volume":"119","author":"Maheu-Cadotte","year":"2019","journal-title":"Am J Nurs"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-Term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1365-2265.2002.01638.x","article-title":"Oxidative stress and normal pregnancy","volume":"57","author":"Toescu","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/cvr\/cvz252","article-title":"Peripartum cardiomyopathy: basic mechanisms and hope for new therapies","volume":"116","author":"Ricke-Hoch","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1161\/01.RES.0000252323.83137.fe","article-title":"Induction of heat shock response protects the heart against atrial fibrillation","volume":"99","author":"Brundel","year":"2006","journal-title":"Circ Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.hrthm.2019.07.010","article-title":"Oral geranylgeranylacetone treatment increases heat shock protein expression in human atrial tissue","volume":"17","author":"van Marion","year":"2020","journal-title":"Heart Rhythm"},{"key":"B60","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2147\/DDDT.S176924","article-title":"Screening of novel HSP-inducing compounds to conserve cardiomyocyte function in experimental atrial fibrillation","volume":"13","author":"van Marion","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"B61","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0014-5793(78)80627-9","article-title":"Inhibition of poly(ADP-ribose) polymerase by methylated xanthines and cytokinins","volume":"88","author":"Levi","year":"1978","journal-title":"FEBS Lett"},{"key":"B62","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00280-016-3124-5","article-title":"Olaparib does not cause clinically relevant QT\/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies","volume":"78","author":"Swaisland","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2013an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","article-title":"Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway","volume":"285","author":"Pillai","year":"2010","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e0186459","DOI":"10.1371\/journal.pone.0186459","article-title":"An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers","volume":"12","author":"Airhart","year":"2017","journal-title":"PLoS ONE"},{"key":"B67","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.yjmcc.2006.06.068","article-title":"Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation","volume":"41","author":"Brundel","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/cvr\/cvn019","article-title":"Effects of a heat shock protein inducer on the atrial fibrillation substrate caused by acute atrial ischaemia","volume":"78","author":"Sakabe","year":"2008","journal-title":"Cardiovasc Res"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2020.00067\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T10:28:24Z","timestamp":1615458504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2020.00067\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":68,"alternative-id":["10.3389\/fcvm.2020.00067"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2020.00067","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"article-number":"67"}}